<Anchor>



I reported a while ago that Pfizer, which sells COVID-19 vaccines around the world, has entered into a contract with a power-gap contract with provisions that infringe on the sovereignty of the other country. Pfizer sent a statement to SBS By pursuing a disclaimer, he hinted that Korea is no exception.



Correspondent Kim Soo-hyung of Washington reports exclusively.



<Reporter>



Public Citizen, an American consumer group that exposed the abuse of Pfizer's corona contract with nine countries around the world.



It was also revealed that Pfizer had put in humiliating provisions exempt from domestic law by forcing Pfizer to waive sovereign immunity in some countries, and that it prevented donations to other countries without Pfizer's permission.



[Zin Lisby/Public Citizen Researcher (last 22nd): Many contracts are very similar. (The Korean contract) seems to contain a problem clause. The Korean government did not disclose the contract with Pfizer, which has its own problem.]



After the report, Pfizer sent a statement to SBS in the name of Pfizer in Korea.



He said that the immunity clause is a general clause in the context of an international public health crisis, and that all countries seek the same immunity, suggesting that South Korea is no exception.



He added that vaccine donations or donations were made in several countries, and there was no intention of interfering with one country's important assets.



However, there was no explanation as to whether they were actually asking for a waiver of sovereign immunity, or whether Pfizer had consented to donate vaccines.



Merck, the American pharmaceutical company that developed the oral coronavirus treatment molnupiravir, has announced that it will allow the manufacture of generic drugs in low-income countries.



As a result, in low-income countries, the cost of a single dose of the drug for five days is expected to be lowered to around 23,000 won by 830,000 won.



The World Health Organization (WHO) welcomed it by saying that it is now possible to manufacture and supply inexpensive treatments around the world.



Merck's decision is also expected to put a lot of pressure on vaccine makers Pfizer and Moderna.



(Video coverage: Oh Jeong-sik, video editing: Jeong Seong-hoon)  



▶ 50's · Underlying disease · Janssen vaccinated 'additional vaccination'


▶ "The only crime is vaccination"...

Victim's first constitutional complaint